Kaiser: Unlimited Possibilities Of Biological Manufacturing Trigger Industrial Pformation

"Throughout the world, the environment of biotechnology industry is not optimistic this year."

After another year, I once again saw Dr. Liu Xiucai, chairman of the Kaisai Biological Industry Co., Ltd. and Dr. CEO, who first threw out the bottleneck problem of the current development environment of biotechnology industry.

Led the R & D team to create bio based polyamide with the "bio manufacturing" method, which has excellent production function, and comprehensively led the application, development and industrialization of bio based polyamide in many fields such as fiber, textile and engineering plastics. As a pioneer in the field of biological manufacturing, in Dr. Liu Xiucai's view, the unfavorable environment is ultimately influenced by cost factors, and the core of the cost problem lies in the block of technical difficulties.

But Dr. Liu has obviously not lost confidence. "The diversity of biological technology will extend the application of products so that the cost can be reduced."

Cost is the absolute principle.

On the basis of reducing costs, increasing the various functions of biological manufacturing products is also the reason why Kay has been widely concerned and become a benchmark case at home and abroad.

Traditional chemical fiber production

Mainly petrochemical materials, statistics show that the global oil energy will probably run out in the 40~60 year.

Under the background of increasingly severe demand for terminal and raw materials, the "contention" of low carbon economy has quietly started in the world.

In this area, biotechnology manufacturing has become the focus of attention.

As a pioneer of biological manufacturing industry, Kaisai biological industry company was founded in 1997, and focused on the industrialization and technology development and practice of bio manufacturing. Large scale industrialization projects include long chain dicarboxylic acid, bio butanol, bio based amyl two amine and bio based polyamide.

Kaisai focuses on developing economically viable biotechnological solutions, and manufacturing new biomaterials through industrial biotechnology to replace special chemical materials that can only be obtained by chemical means or chemically unable to produce.

Kay Sai bio currently has 1 research centers and 2 production bases in China.

The R & D center is located in Zhangjiang hi tech park, Pudong, Shanghai. It is one of the first high-tech R & D institutions stationed in Zhangjiang.

Carpet Market

The beautiful battle of "textile recruits"

For the traditional manufacturing industry, biological technology is a new technology field.

Dr. Liu has also said humbly that for the textile industry, Kaisai is still a "recruits".

All along, Kaisai's business has been growing rapidly, and the competitiveness of enterprises has gained high recognition and recognition in the industry.

But Dr. Liu Xiucai's goal is not to make one or two products and earn money, nor to go too fast, but to hope that Kay can really stay in an industry and a field.

This requires a gradual and gradual promotion process, and more effective breakthrough is needed to open up the awareness of the market.

Because Kay has independent technology research and development system, all technologies are absolutely confidential, while protecting intellectual property rights, it will also cause the industry not to know enough about enterprises and retain reservations to enterprises. This also poses challenges for Kaisai to open up the industry.

In the carpet fiber industry's full spread, has become kaysai's first victory: "this year, we first made some good progress in the carpet industry."

Dr. Liu said.

Nylon 66 is widely used in carpet industry, and its superior function overcomes many problems in the past production process. It soon became popular in the global carpet industry.

Dr. Liu believes that the foundation work of Kay Sai has been very successful in this field, reflecting the excellent performance of products from many aspects, such as color fastness, resilience and abrasion resistance.

The success in this field proves the strength of Kay's fiber function.

In this process, Kay Sai and the leading enterprises in the carpet industry jointly study the product performance and understand the requirements for fiber performance from the demand terminal.

The success of "carpet test" has increased Dr. Liu's confidence and believes that when Kay Sai products are ready to enter the downstream clothing terminal applications, they will have considerable advantages in functionality.

At present, the demand for special fibers and high strength fibers in the domestic market is gradually increasing. The demand of customers for this type of products is very stable, while fixed demand uses high-performance products.

Like this requires tough products, Kay Sai's advantage is very obvious, for this type of market entry is also relatively smooth.

Kaisai has developed many new properties on the biobased polyamide series, and the cost of bio - based manufacturing can be greatly reduced.

Next, Kay will also enter the field of intelligent electronic products, and develop a large number of downstream applications.

The market is vast, and the application in every specific field needs a lot of research and development work. Every new job needs to follow the overall business mode and market development follow up, and it has many challenges.

Therefore, Dr. Liu keeps Kaisai to keep pace with his own development while maintaining a cautious attitude towards the expansion of the new field, and does not blindly accelerate and expand.

"As a biotechnology enterprise, there are still many problems waiting to be solved in the textile industry. This is the challenge and pressure that we are faced with. It is also a problem that we can not evade and must face."

Dr. Liu said so.

At this stage, the state has constantly given policy recognition to the field of bio manufacturing, and more and more attention has been paid to bio manufacturing.

Wusu base

"Pearl along the way" of the bio manufacturing industry

Xinjiang Wusu production base, as a new production base of Kaisai in China, has invested more than 400 million US dollars in the first phase. It is expected to achieve an annual capacity of 50000 tons of bio based amyl two amine, an annual capacity of 100000 tons of bio Based Polyamide and an annual capacity of 30000 tons of long-chain dicarboxylic acid.

The first phase of the project is basically completed and is now being prepared for driving.

At the same time, Kay Sai has begun designing the two phase project of 100 million tons of bio based polyamide, which is expected to achieve 100 billion output value.

In the process of promoting the "one belt and one road" initiative, we have been looking forward to achieving real high-tech projects. The project of kaysaisusu production base is a typical project -- the use of Central Asian agricultural resources and the advantage of energy resources in Xinjiang to effectively reduce costs.

The project also received the attention of the local government, giving support to all aspects, including policies.

The kaisayusu project is expected to achieve normal operation this year. After the project is completed and put into operation, it will become a classic project of "one belt and one road".

"Although there are some difficulties due to various reasons, the advantage of this project is also very obvious.

At the same time, this is also a project that can play a role of demonstration and guidance, which is meaningful both for the region and for the industry. "

Speaking of the importance and industrial value of this project, Dr. Liu showed considerable complacent: "something like this is what I hope to accomplish in my whole life."

TLP

Excellent performance has been recognized by the market and selected for China's fiber fashion trend.

This year, Kaisai new bio Based Polyamide TLC is again selected by the China chemical fiber industry association to host the trend of popular fiber.

This is the second consecutive selection of Thailand products since 2017.

In the first half of the 2018 year of China international textile fabrics and accessories (Chun Xia) exposition, the Kaisai biological and chemical fiber Association jointly organized the "natural, beyond nature" - the pioneer of biological manufacturing industry - Kaisai biological products.

Dr. Liu Xiucai gave a detailed introduction of the latest situation of tlun's products at the press conference, and explained the significance of Kaisai's development of bio based fiber Thailand based on resources, market and biotechnology. "Kaisai is the only biotech company in the world that focuses on bio manufacturing in 20 years.

Kaisai's TLP bio based polyamide series products can provide product solutions for textile downstream industries and reduce dependence on petroleum based raw materials.

TLP as the raw material of textiles can fully display the natural activity of natural cotton, linen, silk and wool, and solve the problem of wearing comfort and cost-effective.

As a new biobased textile material, TLP is the best way to retain the active ingredients of natural fibers. It has the characteristics of soft skin, good moisture absorption, low temperature dyeing and essential resistance.

Compared with the traditional nylon fabric, TLC's fabric has a deeper and brighter color.

TLP can also be blended with cotton, linen and silk. The moisture absorption and skin affinity of the blended fabric are comparable to that of natural materials.

Kay Sai has now realized its development and application in many fields such as spinning, blended yarn, semi worsted, worsted, men's suit, sportswear, military uniform, knitted T shirts, knitted underwear, luggage, carpets and so on.

In the discussion session of the conference, Jiang Shicheng, academician of the Chinese Academy of engineering, said, "Kaisai has developed a new polyamide TLC product with independent intellectual property rights and large-scale industrialization through many years of research and development.

The excellent performance of TLP products can replace the petroleum based polyamide.

This is a new, renewable, and important scientific and technological achievement in the field of biological research.

At present, the 80% synthetic fibers, which are derived from non renewable petroleum based materials, will bring about the greenhouse effect and the exhaustion of resources.

At present, biological fiber has been listed as the key task of the development of textile and chemical fiber industry in 13th Five-Year.

Jiang Xisheng, chairman of the Jiangsu Carrier carpet Limited by Share Ltd, which has long and good cooperation with Kay Sai, said, "in the existing application process, we find that TLC can ensure color fastness and saturation without any fixing agent, which greatly reduces the printing and dyeing wastewater treatment and realizes waterless printing.

This is a major breakthrough in environmental protection.

The natural flame retardant nature of TLP is a good solution to the requirements of fire fighting for printed carpet.

The advantages of TLP in the aspect of abrasion resistance and colourability, compared with traditional nylon, have great prospects in the application of square carpet.

Du Pu, chairman of Liaoning silver pearl Textile Group, believes that the filament made of TLP is good skin affinity, and the dyeing performance of TLP is superior to that of traditional Niron.

"The performance of Talon products has been widely recognized by the market, which is the absolute principle of good products."

Dr. Liu said so.

Shandong production base

Planning the largest pilot base for R & D

For biotechnology, from the project development to the pilot to the production and application, each stage may take three to five years.

The birth of a successful new product or material may take more than a decade or two.

In this process, the whole process support capability of the pilot base is very important.

Kay Sai bio is located in the long chain dicarboxylic acid production base of new material Park in Jining, Shandong. It has been industrialized in 2002 years, and its annual capacity is 40000 tons.

This year, Dr. Liu has new plans and ideas for the Shandong base.

In recent years, Kay Sai is committed to integrating genetic engineering into the bio manufacturing industry.

At present, Kaisai has the ability of screening 500 thousand strains in one year. Usually, 10 to 20 fine strains will be obtained annually, and eventually the frequency of one to two usable strains will be released annually.

Now, Dr. Liu Xiucai's goal is to increase this frequency from one year to two months.

It is not a simple strategic layout to introduce an excellent strain and carry out industrial application in two months.

From the R & D experiment to the application output, the bottleneck of the block speed usually occurs in the pilot stage, and there is still a distance from R & D to industrialization.

Kay Sai is committed to solving this problem by seamlessly linking the distance between the original links.

Therefore, Dr. Liu plans to build a ten thousand square meter pilot base in Shandong Park, and the test results can be directly on the production line.

In the field of biological manufacturing, the pilot scale and production base of this scale was first established.

The production base will strive for the unattended direction, highly NC, and all parameters and analysis must be automated.

Dr Liu Xiucai believes that this project is of great significance for the biological manufacturing industry.

Once the continuous practice from R & D to pilot production to production is realized, it will play a great role in the development of the whole industry, and will also greatly enhance efficiency in the future application in the industry.

Governments at all levels in Shandong's production base also expressed affirmation and support for this project.

New high-tech materials

"Solving problems in principle"

"Biological manufacturing is an industry that needs to be done.

Dr. Liu laughed and said, "do three things well: first, make the performance come out, the two is to lower the price, and the three is to scale up."

But at the same time, Dr. Liu did not want companies to simply pursue sales.

Explore the textile industry, Kaisai do not want to take the old road, like many companies in the past like small profits, rely on the scale of survival.

He hoped that Kay would have a "reasonable profit margin".

The huge annual R & D investment has brought great pressure to kaysai, but Dr. Liu insists that Kaisai must be a research enterprise.

Take polyamide 56, for example, although the technical breakthrough is very difficult, Kaisai must continue to do it.

It is confident that in the textile industry, we will make good use of biological fibers and make excellent functional and cost-effective.

And this hard power is undoubtedly the golden key to open the market space.

As for the textile industry, biotechnology manufacturing is facing many technical problems as a new discipline.

But Dr. Liu is convinced that a technological breakthrough can completely change the face of an industry.

Any breakthrough in the links will bring about a significant drop in costs, which can contribute to the birth of a new industry.

"In the past, people always blindly grabbed the concept, or looked at the technology too simply. Technological breakthroughs were a long-term undertaking. Without solution, they would always be there.

Biological and genetic engineering is developing very fast. Applying these technologies to industrial manufacturing will bring about tremendous changes in the whole industrial structure. "

Dr. Liu hoped that Kay would always grasp the direction of the technology core and be well prepared for talents and technology.

Biological manufacturing industry creates new materials, new materials need new standards, and Dr. Liu's goal is to make Kay Sai design standards for this field.

"In the future, all families in the world will have the standard of Kay race."

Dr. Liu has full confidence. "The standard of biological law is a completely independent system. How to define and determine the case is all right.

We have the expertise and input ability in this area. "

As a standard drafting unit, experts from downstream industries will be drawn up to jointly formulate standards.

Dr. Liu Xiucai has been positioning kaysai in "solving problems in principle": first, from manufacturing, and two from function.

Therefore, although Kay Sai is not a textile origin, he can understand many production problems from principle and solve these problems thoroughly.

Kaisai is not eager to launch new products all the time, but is committed to constantly developing more functions of every product, developing its functionality and making it solid.

Now, Kay Sai's product profit has made many customers do not need to understand the technical principles, but directly trust the future of the product, and choose to use or invest.

In the eyes of Dr. Liu, the diversity of biotechnology manufacturing has unlimited possibilities.

And this infinite possibility is both an opportunity, a challenge and a responsibility.

"There are too many technical problems waiting for us to solve. We need to stick to it and do it.

There are many unknowns in this process, but this is also interesting.

Actually doing science and technology is not a thing of suspension. The more high-tech it is, the more down-to-earth it is.

Liu Xiucai, as always, has a strong reason to believe that the Kay Sai race under his guidance is bound to be able to "never forget the beginning of his mind" in the field of biotechnology manufacturing.